$NEOS Neos Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Neos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Neos Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Neos Therapeutics, Inc. for free.
CIK Number: 0001467652
IRS Number: 270395455
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NEOS
Company Address: 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE 75050
Phone number: 972.408.1360
Market Capitalization: $81.10M
Prev close: $5.00
Average Daily Volume: 201,040
Days Low: $4.95
Year Low: $4.85
Year High: $11.75
Neos Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Option Exercise | D | 1.49 | 115,000 | 171,350 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Option Exercise | D | 3.14 | 150,000 | 471,000 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Limongelli John M | SVP & General Couns ... | Sell | D | 0.00 | 83,015 | 0 | 0 | 83 K to 0 (-100.00 %) |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Option Exercise | D | 1.44 | 46,907 | 67,546 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Option Exercise | D | 2.03 | 12,500 | 25,375 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Sell | D | 0.00 | 23,453 | 0 | 0 | 23.5 K to 0 (-100.00 %) |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 2.31 | 65,447 | 151,183 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 5.55 | 100,000 | 555,000 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 1.49 | 395,000 | 588,550 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 2.31 | 392,688 | 907,109 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Option Exercise | D | 6.20 | 600,000 | 3,720,000 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | McLaughlin Gerald W. | Chief Executive Off ... | Sell | D | 0.00 | 270,171 | 0 | 0 | 270.2 K to 0 (-100.00 %) |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 1.44 | 46,907 | 67,546 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 6.05 | 22,756 | 137,674 | 0 | |
Mar 19 2021 | NEOS | Neos Therapeutics, ... | Hecht Beth | Director | Option Exercise | D | 7.65 | 18,322 | 140,163 | 0 |